{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:44:08Z","timestamp":1794005048441,"version":"4.8.0"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1038\/s41574-022-00733-z","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T07:05:14Z","timestamp":1662534314000},"page":"744-759","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Modelling metabolic diseases and drug response using stem cells and organoids"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6754-5625","authenticated-orcid":false,"given":"Wenxiang","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8653-1280","authenticated-orcid":false,"given":"Mitchell A.","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"733_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/epirev\/mxm012","volume":"29","author":"B Caballero","year":"2007","unstructured":"Caballero, B. The global epidemic of obesity: an overview. Epidemiol. Rev. 29, 1\u20135 (2007).","journal-title":"Epidemiol. Rev."},{"key":"733_CR2","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nature05483","volume":"444","author":"ED Rosen","year":"2006","unstructured":"Rosen, E. D. & Spiegelman, B. M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847\u2013853 (2006).","journal-title":"Nature"},{"key":"733_CR3","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(00)04616-X","volume":"357","author":"BI Joffe","year":"2001","unstructured":"Joffe, B. I., Panz, V. R. & Raal, F. J. From lipodystrophy syndromes to diabetes mellitus. Lancet 357, 1379\u20131381 (2001).","journal-title":"Lancet"},{"key":"733_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2147\/DMSO.S67400","volume":"7","author":"AS Al-Goblan","year":"2014","unstructured":"Al-Goblan, A. S., Al-Alfi, M. A. & Khan, M. Z. Mechanism linking diabetes mellitus and obesity. Diabetes Metab. Syndr. Obes. 7, 587\u2013591 (2014).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"733_CR5","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrm.2016.96","volume":"17","author":"W Wang","year":"2016","unstructured":"Wang, W. & Seale, P. Control of brown and beige fat development. Nat. Rev. Mol. Cell Biol. 17, 691\u2013702 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"733_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.tips.2005.03.003","volume":"26","author":"JP Berger","year":"2005","unstructured":"Berger, J. P., Akiyama, T. E. & Meinke, P. T. PPARs: therapeutic targets for metabolic disease. Trends Pharmacol. Sci. 26, 244\u2013251 (2005).","journal-title":"Trends Pharmacol. Sci."},{"key":"733_CR7","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/ijms17040572","volume":"17","author":"A Kurylowicz","year":"2016","unstructured":"Kurylowicz, A. In search of new therapeutic targets in obesity treatment: sirtuins. Int. J. Mol. Sci. 17, 572 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"733_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cmet.2020.07.005","volume":"32","author":"DP Blondin","year":"2020","unstructured":"Blondin, D. P. et al. Human brown adipocyte thermogenesis is driven by \u03b22-AR stimulation. Cell Metab. 32, 287\u2013300.e7 (2020).","journal-title":"Cell Metab."},{"key":"733_CR9","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s42255-019-0101-4","volume":"1","author":"JMA de Jong","year":"2019","unstructured":"de Jong, J. M. A. et al. Human brown adipose tissue is phenocopied by classical brown adipose tissue in physiologically humanized mice. Nat. Metab. 1, 830\u2013843 (2019).","journal-title":"Nat. Metab."},{"key":"733_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev-physiol-021113-170255","volume":"77","author":"BZ Stanger","year":"2015","unstructured":"Stanger, B. Z. Cellular homeostasis and repair in the mammalian liver. Annu. Rev. Physiol. 77, 179\u2013200 (2015).","journal-title":"Annu. Rev. Physiol."},{"key":"733_CR11","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","volume":"20","author":"WC Zhou","year":"2014","unstructured":"Zhou, W. C., Zhang, Q. B. & Qiao, L. Pathogenesis of liver cirrhosis. World J. Gastroenterol. 20, 7312\u20137324 (2014).","journal-title":"World J. Gastroenterol."},{"key":"733_CR12","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.cell.2008.09.001","volume":"134","author":"JM Olefsky","year":"2008","unstructured":"Olefsky, J. M. Fat talks, liver and muscle listen. Cell 134, 914\u2013916 (2008).","journal-title":"Cell"},{"key":"733_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nature13478","volume":"510","author":"RJ Perry","year":"2014","unstructured":"Perry, R. J., Samuel, V. T., Petersen, K. F. & Shulman, G. I. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 510, 84\u201391 (2014).","journal-title":"Nature"},{"key":"733_CR14","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201947903","volume":"20","author":"J Castillo-Armengol","year":"2019","unstructured":"Castillo-Armengol, J., Fajas, L. & Lopez-Mejia, I. C. Inter-organ communication: a gatekeeper for metabolic health. EMBO Rep. 20, e47903 (2019).","journal-title":"EMBO Rep."},{"key":"733_CR15","doi-asserted-by":"publisher","first-page":"101138","DOI":"10.1016\/j.molmet.2020.101138","volume":"44","author":"SO Jensen-Cody","year":"2021","unstructured":"Jensen-Cody, S. O. & Potthoff, M. J. Hepatokines and metabolism: deciphering communication from the liver. Mol. Metab. 44, 101138 (2021).","journal-title":"Mol. Metab."},{"key":"733_CR16","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jhep.2021.05.022","volume":"75","author":"P Golabi","year":"2021","unstructured":"Golabi, P. et al. Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: data from Global Burden of Disease 2009\u20132019. J. Hepatol. 75, 795\u2013809 (2021).","journal-title":"J. Hepatol."},{"key":"733_CR17","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","volume":"10","author":"GA Michelotti","year":"2013","unstructured":"Michelotti, G. A., Machado, M. V. & Diehl, A. M. NAFLD, NASH and liver cancer. Nat. Rev. Gastroenterol. Hepatol. 10, 656\u2013665 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"733_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/joim.13069","volume":"288","author":"B Zou","year":"2020","unstructured":"Zou, B. et al. Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016. J. Intern. Med. 288, 139\u2013151 (2020).","journal-title":"J. Intern. Med."},{"key":"733_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41575-020-00408-y","volume":"18","author":"R Vuppalanchi","year":"2021","unstructured":"Vuppalanchi, R., Noureddin, M., Alkhouri, N. & Sanyal, A. J. Therapeutic pipeline in nonalcoholic steatohepatitis. Nat. Rev. Gastroenterol. Hepatol. 18, 373\u2013392 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"733_CR20","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145\u20131147 (1998).","journal-title":"Science"},{"key":"733_CR21","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872 (2007).","journal-title":"Cell"},{"key":"733_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663\u2013676 (2006).","journal-title":"Cell"},{"key":"733_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.stem.2020.02.011","volume":"26","author":"A Sharma","year":"2020","unstructured":"Sharma, A., Sances, S., Workman, M. J. & Svendsen, C. N. Multi-lineage human iPSC-derived platforms for disease modeling and drug discovery. Cell Stem Cell 26, 309\u2013329 (2020).","journal-title":"Cell Stem Cell"},{"key":"733_CR24","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.stem.2021.04.005","volume":"28","author":"A Marsee","year":"2021","unstructured":"Marsee, A. et al. Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids. Cell Stem Cell 28, 816\u2013832 (2021).","journal-title":"Cell Stem Cell"},{"key":"733_CR25","doi-asserted-by":"publisher","first-page":"1700089","DOI":"10.1002\/bies.201700089","volume":"39","author":"JA Bolker","year":"2017","unstructured":"Bolker, J. A. Animal models in translational research: rosetta stone or stumbling block? Bioessays 39, 1700089 (2017).","journal-title":"Bioessays"},{"key":"733_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrd1012","volume":"2","author":"DF Horrobin","year":"2003","unstructured":"Horrobin, D. F. Modern biomedical research: an internally self-consistent universe with little contact with medical reality? Nat. Rev. Drug Discov. 2, 151\u2013154 (2003).","journal-title":"Nat. Rev. Drug Discov."},{"key":"733_CR27","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/453840a","volume":"453","author":"D Butler","year":"2008","unstructured":"Butler, D. Translational research: crossing the valley of death. Nature 453, 840\u2013842 (2008).","journal-title":"Nature"},{"key":"733_CR28","doi-asserted-by":"publisher","first-page":"103549","DOI":"10.1016\/j.isci.2021.103549","volume":"25","author":"MJ Ramos","year":"2022","unstructured":"Ramos, M. J., Bandiera, L., Menolascina, F. & Fallowfield, J. A. In vitro models for non-alcoholic fatty liver disease: emerging platforms and their applications. iScience 25, 103549 (2022).","journal-title":"iScience"},{"key":"733_CR29","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1517\/13543784.2015.1058777","volume":"24","author":"JR Colca","year":"2015","unstructured":"Colca, J. R. Discontinued drug therapies to treat diabetes in 2014. Expert. Opin. Investig. Drugs 24, 1241\u20131245 (2015).","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"733_CR30","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1517\/13543780903132673","volume":"18","author":"JR Colca","year":"2009","unstructured":"Colca, J. R. Discontinued drugs in 2008: endocrine and metabolic. Expert. Opin. Investig. Drugs 18, 1243\u20131255 (2009).","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"733_CR31","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1093\/eurheartj\/ehx568","volume":"39","author":"S Costantino","year":"2018","unstructured":"Costantino, S. et al. Epigenetics and precision medicine in cardiovascular patients: from basic concepts to the clinical arena. Eur. Heart J. 39, 4150\u20134158 (2018).","journal-title":"Eur. Heart J."},{"key":"733_CR32","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/pr.2014.128","volume":"76","author":"A Krishnan","year":"2014","unstructured":"Krishnan, A. et al. A detailed comparison of mouse and human cardiac development. Pediatr. Res. 76, 500\u2013507 (2014).","journal-title":"Pediatr. Res."},{"key":"733_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14250","volume":"8","author":"EM Blais","year":"2017","unstructured":"Blais, E. M. et al. Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions. Nat. Commun. 8, 14250 (2017).","journal-title":"Nat. Commun."},{"key":"733_CR34","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1517\/17425255.2.6.875","volume":"2","author":"M Martignoni","year":"2006","unstructured":"Martignoni, M., Groothuis, G. M. & de Kanter, R. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert. Opin. Drug Metab. Toxicol. 2, 875\u2013894 (2006).","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"733_CR35","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","volume":"159","author":"RJ Platt","year":"2014","unstructured":"Platt, R. J. et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159, 440\u2013455 (2014).","journal-title":"Cell"},{"key":"733_CR36","doi-asserted-by":"publisher","first-page":"aaf5573","DOI":"10.1126\/science.aaf5573","volume":"353","author":"OO Abudayyeh","year":"2016","unstructured":"Abudayyeh, O. O. et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science 353, aaf5573 (2016).","journal-title":"Science"},{"key":"733_CR37","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471 (2017).","journal-title":"Nature"},{"key":"733_CR38","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.stem.2016.07.002","volume":"19","author":"H Zeng","year":"2016","unstructured":"Zeng, H. et al. An isogenic human ESC platform for functional evaluation of genome-wide-association-study-identified diabetes genes and drug discovery. Cell Stem Cell 19, 326\u2013340 (2016).","journal-title":"Cell Stem Cell"},{"key":"733_CR39","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41581-020-0298-1","volume":"16","author":"KM Sullivan","year":"2020","unstructured":"Sullivan, K. M. & Susztak, K. Unravelling the complex genetics of common kidney diseases: from variants to mechanisms. Nat. Rev. Nephrol. 16, 628\u2013640 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"733_CR40","doi-asserted-by":"publisher","first-page":"eaaf9414","DOI":"10.1126\/science.aaf9414","volume":"355","author":"AL Bredenoord","year":"2017","unstructured":"Bredenoord, A. L., Clevers, H. & Knoblich, J. A. Human tissues in a dish: the research and ethical implications of organoid technology. Science 355, eaaf9414 (2017).","journal-title":"Science"},{"key":"733_CR41","doi-asserted-by":"publisher","first-page":"1247125","DOI":"10.1126\/science.1247125","volume":"345","author":"MA Lancaster","year":"2014","unstructured":"Lancaster, M. A. & Knoblich, J. A. Organogenesis in a dish: modeling development and disease using organoid technologies. Science 345, 1247125 (2014).","journal-title":"Science"},{"key":"733_CR42","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature07935","volume":"459","author":"T Sato","year":"2009","unstructured":"Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262\u2013265 (2009).","journal-title":"Nature"},{"key":"733_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmeth.4575","volume":"15","author":"[No authors listed].","year":"2018","unstructured":"[No authors listed]. Method of the year 2017: organoids. Nat. Methods 15, 1 (2018).","journal-title":"Nat. Methods"},{"key":"733_CR44","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","volume":"501","author":"MA Lancaster","year":"2013","unstructured":"Lancaster, M. A. et al. Cerebral organoids model human brain development and microcephaly. Nature 501, 373\u2013379 (2013).","journal-title":"Nature"},{"key":"733_CR45","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41596-018-0104-8","volume":"14","author":"AJ Miller","year":"2019","unstructured":"Miller, A. J. et al. Generation of lung organoids from human pluripotent stem cells in vitro. Nat. Protoc. 14, 518\u2013540 (2019).","journal-title":"Nat. Protoc."},{"key":"733_CR46","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/nbt.3392","volume":"33","author":"R Morizane","year":"2015","unstructured":"Morizane, R. et al. Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat. Biotechnol. 33, 1193\u20131200 (2015).","journal-title":"Nat. Biotechnol."},{"key":"733_CR47","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s13238-021-00831-0","volume":"13","author":"X Zhang","year":"2021","unstructured":"Zhang, X., Ma, Z., Song, E. & Xu, T. Islet organoid as a promising model for diabetes. Protein Cell 13, 239\u2013257 (2021).","journal-title":"Protein Cell"},{"key":"733_CR48","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.cell.2018.11.013","volume":"175","author":"H Hu","year":"2018","unstructured":"Hu, H. et al. Long-term expansion of functional mouse and human hepatocytes as 3D organoids. Cell 175, 1591\u20131606.e19 (2018).","journal-title":"Cell"},{"key":"733_CR49","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1016\/j.cell.2021.04.034","volume":"184","author":"P Hofbauer","year":"2021","unstructured":"Hofbauer, P. et al. Cardioids reveal self-organizing principles of human cardiogenesis. Cell 184, 3299\u20133317.e22 (2021).","journal-title":"Cell"},{"key":"733_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43624-6","volume":"9","author":"S Muller","year":"2019","unstructured":"Muller, S. et al. Human adipose stromal-vascular fraction self-organizes to form vascularized adipose tissue in 3D cultures. Sci. Rep. 9, 7250 (2019).","journal-title":"Sci. Rep."},{"key":"733_CR51","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.stem.2019.11.011","volume":"26","author":"JR Alvarez-Dominguez","year":"2020","unstructured":"Alvarez-Dominguez, J. R. et al. Circadian entrainment triggers maturation of human in vitro islets. Cell Stem Cell 26, 108\u2013122.e10 (2020).","journal-title":"Cell Stem Cell"},{"key":"733_CR52","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/nm.4355","volume":"23","author":"M Crespo","year":"2017","unstructured":"Crespo, M. et al. Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing. Nat. Med. 23, 878\u2013884 (2017).","journal-title":"Nat. Med."},{"key":"733_CR53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41576-020-00292-x","volume":"22","author":"E Armingol","year":"2021","unstructured":"Armingol, E., Officer, A., Harismendy, O. & Lewis, N. E. Deciphering cell-cell interactions and communication from gene expression. Nat. Rev. Genet. 22, 71\u201388 (2021).","journal-title":"Nat. Rev. Genet."},{"key":"733_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4143\/crt.2017.307","volume":"50","author":"J Jung","year":"2018","unstructured":"Jung, J., Seol, H. S. & Chang, S. The generation and application of patient-derived xenograft model for cancer research. Cancer Res. Treat. 50, 1\u201310 (2018).","journal-title":"Cancer Res. Treat."},{"key":"733_CR55","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41574-018-0132-z","volume":"15","author":"M Bakhti","year":"2019","unstructured":"Bakhti, M., Bottcher, A. & Lickert, H. Modelling the endocrine pancreas in health and disease. Nat. Rev. Endocrinol. 15, 155\u2013171 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"733_CR56","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.2337\/db16-1107","volume":"66","author":"AC Guenantin","year":"2017","unstructured":"Guenantin, A. C. et al. Functional human beige adipocytes from induced pluripotent stem cells. Diabetes 66, 1470\u20131478 (2017).","journal-title":"Diabetes"},{"key":"733_CR57","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1002\/stem.1607","volume":"32","author":"T Mohsen-Kanson","year":"2014","unstructured":"Mohsen-Kanson, T. et al. Differentiation of human induced pluripotent stem cells into brown and white adipocytes: role of Pax3. Stem Cell 32, 1459\u20131467 (2014).","journal-title":"Stem Cell"},{"key":"733_CR58","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ncb2411","volume":"14","author":"T Ahfeldt","year":"2012","unstructured":"Ahfeldt, T. et al. Programming human pluripotent stem cells into white and brown adipocytes. Nat. Cell Biol. 14, 209\u2013219 (2012).","journal-title":"Nat. Cell Biol."},{"key":"733_CR59","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1089\/scd.2005.14.671","volume":"14","author":"C Xiong","year":"2005","unstructured":"Xiong, C. et al. Derivation of adipocytes from human embryonic stem cells. Stem Cell Dev. 14, 671\u2013675 (2005).","journal-title":"Stem Cell Dev."},{"key":"733_CR60","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.cmet.2012.08.001","volume":"16","author":"M Nishio","year":"2012","unstructured":"Nishio, M. et al. Production of functional classical brown adipocytes from human pluripotent stem cells using specific hemopoietin cocktail without gene transfer. Cell Metab. 16, 394\u2013406 (2012).","journal-title":"Cell Metab."},{"key":"733_CR61","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.stem.2020.07.013","volume":"27","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Generation of functional brown adipocytes from human pluripotent stem cells via progression through a paraxial mesoderm state. Cell Stem Cell 27, 784\u2013797.e11 (2020).","journal-title":"Cell Stem Cell"},{"key":"733_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/nyas.14257","volume":"1463","author":"AC Brown","year":"2020","unstructured":"Brown, A. C. Brown adipocytes from induced pluripotent stem cells-how far have we come? Ann. N. Y. Acad. Sci. 1463, 9\u201322 (2020).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"733_CR63","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.scr.2018.04.007","volume":"30","author":"S Mukherjee","year":"2018","unstructured":"Mukherjee, S. et al. Derivation and characterization of a UCP1 reporter human ES cell line. Stem Cell Res. 30, 12\u201321 (2018).","journal-title":"Stem Cell Res."},{"key":"733_CR64","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/nature08262","volume":"460","author":"S Kajimura","year":"2009","unstructured":"Kajimura, S. et al. Initiation of myoblast to brown fat switch by a PRDM16-C\/EBP-\u03b2 transcriptional complex. Nature 460, 1154\u20131158 (2009).","journal-title":"Nature"},{"key":"733_CR65","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3389\/fendo.2018.00694","volume":"9","author":"H Wang","year":"2018","unstructured":"Wang, H., Leng, Y. & Gong, Y. Bone marrow fat and hematopoiesis. Front. Endocrinol. 9, 694 (2018).","journal-title":"Front. Endocrinol."},{"key":"733_CR66","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1016\/j.celrep.2018.11.037","volume":"25","author":"S Su","year":"2018","unstructured":"Su, S. et al. A renewable source of human beige adipocytes for development of therapies to treat metabolic syndrome. Cell Rep. 25, 3215\u20133228.e9 (2018).","journal-title":"Cell Rep."},{"key":"733_CR67","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-physiol-031620-095446","volume":"83","author":"S Corvera","year":"2021","unstructured":"Corvera, S. Cellular heterogeneity in adipose tissues. Annu. Rev. Physiol. 83, 257\u2013278 (2021).","journal-title":"Annu. Rev. Physiol."},{"key":"733_CR68","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.3390\/cells9102326","volume":"9","author":"HF Bahmad","year":"2020","unstructured":"Bahmad, H. F. et al. Modeling adipogenesis: current and future perspective. Cells 9, 2326 (2020).","journal-title":"Cells"},{"key":"733_CR69","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1210\/en.2015-1567","volume":"156","author":"MP Emont","year":"2015","unstructured":"Emont, M. P. et al. Using a 3D culture system to differentiate visceral adipocytes in vitro. Endocrinology 156, 4761\u20134768 (2015).","journal-title":"Endocrinology"},{"key":"733_CR70","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.procbio.2017.02.003","volume":"59","author":"PA Turner","year":"2017","unstructured":"Turner, P. A., Gurumurthy, B., Bailey, J. L., Elks, C. M. & Janorkar, A. V. Adipogenic differentiation of human adipose-derived stem cells grown as spheroids. Process. Biochem. 59, 312\u2013320 (2017).","journal-title":"Process. Biochem."},{"key":"733_CR71","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s42003-021-02910-8","volume":"4","author":"MT Kozlowski","year":"2021","unstructured":"Kozlowski, M. T., Crook, C. J. & Ku, H. T. Towards organoid culture without Matrigel. Commun. Biol. 4, 1387 (2021).","journal-title":"Commun. Biol."},{"key":"733_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-19024-z","volume":"8","author":"AJ Klingelhutz","year":"2018","unstructured":"Klingelhutz, A. J. et al. Scaffold-free generation of uniform adipose spheroids for metabolism research and drug discovery. Sci. Rep. 8, 523 (2018).","journal-title":"Sci. Rep."},{"key":"733_CR73","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/stem.2336","volume":"34","author":"A Di Franco","year":"2016","unstructured":"Di Franco, A. et al. Searching for classical brown fat in humans: development of a novel human fetal brown stem cell model. Stem Cell 34, 1679\u20131691 (2016).","journal-title":"Stem Cell"},{"key":"733_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78015-9","volume":"10","author":"J Taylor","year":"2020","unstructured":"Taylor, J. et al. Generation of immune cell containing adipose organoids for in vitro analysis of immune metabolism. Sci. Rep. 10, 21104 (2020).","journal-title":"Sci. Rep."},{"key":"733_CR75","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature11132","volume":"486","author":"D Cipolletta","year":"2012","unstructured":"Cipolletta, D. et al. PPAR-\u03b3 is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486, 549\u2013553 (2012).","journal-title":"Nature"},{"key":"733_CR76","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1089\/ten.tea.2008.0469","volume":"15","author":"JH Kang","year":"2009","unstructured":"Kang, J. H., Gimble, J. M. & Kaplan, D. L. In vitro 3D model for human vascularized adipose tissue. Tissue Eng. Part. A 15, 2227\u20132236 (2009).","journal-title":"Tissue Eng. Part. A"},{"key":"733_CR77","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1016\/j.actbio.2010.05.005","volume":"6","author":"N Davidenko","year":"2010","unstructured":"Davidenko, N., Campbell, J. J., Thian, E. S., Watson, C. J. & Cameron, R. E. Collagen-hyaluronic acid scaffolds for adipose tissue engineering. Acta Biomater. 6, 3957\u20133968 (2010).","journal-title":"Acta Biomater."},{"key":"733_CR78","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.actbio.2018.03.021","volume":"71","author":"M Kuss","year":"2018","unstructured":"Kuss, M. et al. Effects of tunable, 3D-bioprinted hydrogels on human brown adipocyte behavior and metabolic function. Acta Biomater. 71, 486\u2013495 (2018).","journal-title":"Acta Biomater."},{"key":"733_CR79","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1089\/ten.teb.2019.0261","volume":"26","author":"M McCarthy","year":"2020","unstructured":"McCarthy, M. et al. Fat-on-a-chip models for research and discovery in obesity and its metabolic comorbidities. Tissue Eng. Part. B Rev. 26, 586\u2013595 (2020).","journal-title":"Tissue Eng. Part. B Rev."},{"key":"733_CR80","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s42490-019-0027-7","volume":"1","author":"CS Murphy","year":"2019","unstructured":"Murphy, C. S., Liaw, L. & Reagan, M. R. In vitro tissue-engineered adipose constructs for modeling disease. BMC Biomed. Eng. 1, 27 (2019).","journal-title":"BMC Biomed. Eng."},{"key":"733_CR81","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-1-4939-7799-4_12","volume":"1773","author":"H Tseng","year":"2018","unstructured":"Tseng, H., Daquinag, A. C., Souza, G. R. & Kolonin, M. G. Three-dimensional magnetic levitation culture system simulating white adipose tissue. Methods Mol. Biol. 1773, 147\u2013154 (2018).","journal-title":"Methods Mol. Biol."},{"key":"733_CR82","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature11826","volume":"494","author":"M Huch","year":"2013","unstructured":"Huch, M. et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature 494, 247\u2013250 (2013).","journal-title":"Nature"},{"key":"733_CR83","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","volume":"160","author":"M Huch","year":"2015","unstructured":"Huch, M. et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160, 299\u2013312 (2015).","journal-title":"Cell"},{"key":"733_CR84","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.cell.2018.11.012","volume":"175","author":"WC Peng","year":"2018","unstructured":"Peng, W. C. et al. Inflammatory cytokine TNF\u03b1 promotes the long-term expansion of primary hepatocytes in 3D culture. Cell 175, 1607\u20131619.e15 (2018).","journal-title":"Cell"},{"key":"733_CR85","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-021-00373-7","volume":"22","author":"L Campana","year":"2021","unstructured":"Campana, L., Esser, H., Huch, M. & Forbes, S. Liver regeneration and inflammation: from fundamental science to clinical applications. Nat. Rev. Mol. Cell Biol. 22, 608\u2013624 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"733_CR86","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/s41556-019-0359-5","volume":"21","author":"L Sun","year":"2019","unstructured":"Sun, L. et al. Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes. Nat. Cell Biol. 21, 1015\u20131026 (2019).","journal-title":"Nat. Cell Biol."},{"key":"733_CR87","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1136\/gutjnl-2019-319256","volume":"68","author":"N Prior","year":"2019","unstructured":"Prior, N., Inacio, P. & Huch, M. Liver organoids: from basic research to therapeutic applications. Gut 68, 2228\u20132237 (2019).","journal-title":"Gut"},{"key":"733_CR88","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature12271","volume":"499","author":"T Takebe","year":"2013","unstructured":"Takebe, T. et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499, 481\u2013484 (2013).","journal-title":"Nature"},{"key":"733_CR89","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.jhep.2018.01.005","volume":"68","author":"EA Ober","year":"2018","unstructured":"Ober, E. A. & Lemaigre, F. P. Development of the liver: insights into organ and tissue morphogenesis. J. Hepatol. 68, 1049\u20131062 (2018).","journal-title":"J. Hepatol."},{"key":"733_CR90","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1016\/j.celrep.2017.11.005","volume":"21","author":"T Takebe","year":"2017","unstructured":"Takebe, T. et al. Massive and reproducible production of liver buds entirely from human pluripotent stem cells. Cell Rep. 21, 2661\u20132670 (2017).","journal-title":"Cell Rep."},{"key":"733_CR91","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13619-021-00089-1","volume":"10","author":"D Lam","year":"2021","unstructured":"Lam, D., Dan, Y. Y., Chan, Y. S. & Ng, H. H. Emerging liver organoid platforms and technologies. Cell Regen. 10, 27 (2021).","journal-title":"Cell Regen."},{"key":"733_CR92","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1242\/dev.029140","volume":"136","author":"Y Zong","year":"2009","unstructured":"Zong, Y. et al. Notch signaling controls liver development by regulating biliary differentiation. Development 136, 1727\u20131739 (2009).","journal-title":"Development"},{"key":"733_CR93","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/hep.27165","volume":"60","author":"N Dianat","year":"2014","unstructured":"Dianat, N. et al. Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells. Hepatology 60, 700\u2013714 (2014).","journal-title":"Hepatology"},{"key":"733_CR94","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nbt.3294","volume":"33","author":"M Ogawa","year":"2015","unstructured":"Ogawa, M. et al. Directed differentiation of cholangiocytes from human pluripotent stem cells. Nat. Biotechnol. 33, 853\u2013861 (2015).","journal-title":"Nat. Biotechnol."},{"key":"733_CR95","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nprot.2017.011","volume":"12","author":"F Sampaziotis","year":"2017","unstructured":"Sampaziotis, F. et al. Directed differentiation of human induced pluripotent stem cells into functional cholangiocyte-like cells. Nat. Protoc. 12, 814\u2013827 (2017).","journal-title":"Nat. Protoc."},{"key":"733_CR96","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1126\/science.aaz6964","volume":"371","author":"F Sampaziotis","year":"2021","unstructured":"Sampaziotis, F. et al. Cholangiocyte organoids can repair bile ducts after transplantation in the human liver. Science 371, 839\u2013846 (2021).","journal-title":"Science"},{"key":"733_CR97","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.94954","volume":"2","author":"Y Guan","year":"2017","unstructured":"Guan, Y. et al. Human hepatic organoids for the analysis of human genetic diseases. JCI Insight 2, e94954 (2017).","journal-title":"JCI Insight"},{"key":"733_CR98","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jhep.2018.12.028","volume":"70","author":"F Wu","year":"2019","unstructured":"Wu, F. et al. Generation of hepatobiliary organoids from human induced pluripotent stem cells. J. Hepatol. 70, 1145\u20131158 (2019).","journal-title":"J. Hepatol."},{"key":"733_CR99","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1053\/j.gastro.2020.06.010","volume":"159","author":"MNB Ramli","year":"2020","unstructured":"Ramli, M. N. B. et al. Human pluripotent stem cell-derived organoids as models of liver disease. Gastroenterology 159, 1471\u20131486.e12 (2020).","journal-title":"Gastroenterology"},{"key":"733_CR100","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.stemcr.2019.08.007","volume":"13","author":"S Akbari","year":"2019","unstructured":"Akbari, S. et al. Robust, long-term culture of endoderm-derived hepatic organoids for disease modeling. Stem Cell Rep. 13, 627\u2013641 (2019).","journal-title":"Stem Cell Rep."},{"key":"733_CR101","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","volume":"30","author":"R Ouchi","year":"2019","unstructured":"Ouchi, R. et al. Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids. Cell Metab. 30, 374\u2013384.e6 (2019).","journal-title":"Cell Metab."},{"key":"733_CR102","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1053\/j.gastro.2020.10.002","volume":"160","author":"T Shinozawa","year":"2021","unstructured":"Shinozawa, T. et al. High-fidelity drug-induced liver injury screen using human pluripotent stem cell-derived organoids. Gastroenterology 160, 831\u2013846.e10 (2021).","journal-title":"Gastroenterology"},{"key":"733_CR103","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41586-019-1598-0","volume":"574","author":"H Koike","year":"2019","unstructured":"Koike, H. et al. Modelling human hepato-biliary-pancreatic organogenesis from the foregut-midgut boundary. Nature 574, 112\u2013116 (2019).","journal-title":"Nature"},{"key":"733_CR104","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.stem.2018.12.015","volume":"24","author":"Y Xiang","year":"2019","unstructured":"Xiang, Y. et al. hESC-derived thalamic organoids form reciprocal projections when fused with cortical organoids. Cell Stem Cell 24, 487\u2013497.e7 (2019).","journal-title":"Cell Stem Cell"},{"key":"733_CR105","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.stem.2017.07.007","volume":"21","author":"Y Xiang","year":"2017","unstructured":"Xiang, Y. et al. Fusion of regionally specified hPSC-derived organoids models human brain development and interneuron migration. Cell Stem Cell 21, 383\u2013398.e7 (2017).","journal-title":"Cell Stem Cell"},{"key":"733_CR106","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/s41587-020-00763-w","volume":"38","author":"Y Miura","year":"2020","unstructured":"Miura, Y. et al. Generation of human striatal organoids and cortico-striatal assembloids from human pluripotent stem cells. Nat. Biotechnol. 38, 1421\u20131430 (2020).","journal-title":"Nat. Biotechnol."},{"key":"733_CR107","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.medj.2021.08.005","volume":"2","author":"S Bose","year":"2021","unstructured":"Bose, S., Clevers, H. & Shen, X. Promises and challenges of organoid-guided precision medicine. Med 2, 1011\u20131026 (2021).","journal-title":"Med"},{"key":"733_CR108","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1126\/science.aao3130","volume":"358","author":"J Drost","year":"2017","unstructured":"Drost, J. et al. Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer. Science 358, 234\u2013238 (2017).","journal-title":"Science"},{"key":"733_CR109","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1161\/CIRCRESAHA.116.308999","volume":"118","author":"PE Scherer","year":"2016","unstructured":"Scherer, P. E. & Hill, J. A. Obesity, diabetes, and cardiovascular diseases: a compendium. Circ. Res. 118, 1703\u20131705 (2016).","journal-title":"Circ. Res."},{"key":"733_CR110","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.106.675355","volume":"116","author":"CS Fox","year":"2007","unstructured":"Fox, C. S. et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116, 39\u201348 (2007).","journal-title":"Circulation"},{"key":"733_CR111","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrendo.2014.185","volume":"11","author":"F Karpe","year":"2015","unstructured":"Karpe, F. & Pinnick, K. E. Biology of upper-body and lower-body adipose tissue \u2013 link to whole-body phenotypes. Nat. Rev. Endocrinol. 11, 90\u2013100 (2015).","journal-title":"Nat. Rev. Endocrinol."},{"key":"733_CR112","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.2337\/db11-1753","volume":"61","author":"Y Macotela","year":"2012","unstructured":"Macotela, Y. et al. Intrinsic differences in adipocyte precursor cells from different white fat depots. Diabetes 61, 1691\u20131699 (2012).","journal-title":"Diabetes"},{"key":"733_CR113","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1242\/dev.067686","volume":"138","author":"J Han","year":"2011","unstructured":"Han, J. et al. The spatiotemporal development of adipose tissue. Development 138, 5027\u20135037 (2011).","journal-title":"Development"},{"key":"733_CR114","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.diff.2016.02.003","volume":"92","author":"AC Volz","year":"2016","unstructured":"Volz, A. C., Huber, B. & Kluger, P. J. Adipose-derived stem cell differentiation as a basic tool for vascularized adipose tissue engineering. Differentiation 92, 52\u201364 (2016).","journal-title":"Differentiation"},{"key":"733_CR115","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fendo.2011.00102","volume":"2","author":"S Collins","year":"2011","unstructured":"Collins, S. \u03b2-Adrenoceptor signaling networks in adipocytes for recruiting stored fat and energy expenditure. Front. Endocrinol. 2, 102 (2011).","journal-title":"Front. Endocrinol."},{"key":"733_CR116","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41573-020-0079-3","volume":"20","author":"LA Low","year":"2021","unstructured":"Low, L. A., Mummery, C., Berridge, B. R., Austin, C. P. & Tagle, D. A. Organs-on-chips: into the next decade. Nat. Rev. Drug Discov. 20, 345\u2013361 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"733_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92264-2","volume":"11","author":"VL Slaughter","year":"2021","unstructured":"Slaughter, V. L. et al. Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation. Sci. Rep. 11, 13159 (2021).","journal-title":"Sci. Rep."},{"key":"733_CR118","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature14132","volume":"518","author":"D Shungin","year":"2015","unstructured":"Shungin, D. et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518, 187\u2013196 (2015).","journal-title":"Nature"},{"key":"733_CR119","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature14177","volume":"518","author":"AE Locke","year":"2015","unstructured":"Locke, A. E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197\u2013206 (2015).","journal-title":"Nature"},{"key":"733_CR120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018939","volume":"6","author":"K Wang","year":"2011","unstructured":"Wang, K. et al. A genome-wide association study on obesity and obesity-related traits. PLoS ONE 6, e18939 (2011).","journal-title":"PLoS ONE"},{"key":"733_CR121","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.stem.2017.01.010","volume":"20","author":"CR Warren","year":"2017","unstructured":"Warren, C. R. et al. Induced pluripotent stem cell differentiation enables functional validation of GWAS variants in metabolic disease. Cell Stem Cell 20, 547\u2013557.e7 (2017).","journal-title":"Cell Stem Cell"},{"key":"733_CR122","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.stem.2012.11.011","volume":"12","author":"Q Ding","year":"2013","unstructured":"Ding, Q. et al. A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell 12, 238\u2013251 (2013).","journal-title":"Cell Stem Cell"},{"key":"733_CR123","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41586-019-1373-2","volume":"572","author":"N Aizarani","year":"2019","unstructured":"Aizarani, N. et al. A human liver cell atlas reveals heterogeneity and epithelial progenitors. Nature 572, 199\u2013204 (2019).","journal-title":"Nature"},{"key":"733_CR124","doi-asserted-by":"publisher","first-page":"665987","DOI":"10.3389\/fendo.2021.665987","volume":"12","author":"S Albhaisi","year":"2021","unstructured":"Albhaisi, S. & Sanyal, A. J. Gene-environmental interactions as metabolic drivers of nonalcoholic steatohepatitis. Front. Endocrinol. 12, 665987 (2021).","journal-title":"Front. Endocrinol."},{"key":"733_CR125","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41591-021-01344-3","volume":"27","author":"A Deczkowska","year":"2021","unstructured":"Deczkowska, A. et al. XCR1(+) type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis. Nat. Med. 27, 1043\u20131054 (2021).","journal-title":"Nat. Med."},{"key":"733_CR126","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.immuni.2020.04.001","volume":"52","author":"JS Seidman","year":"2020","unstructured":"Seidman, J. S. et al. Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis. Immunity 52, 1057\u20131074.e7 (2020).","journal-title":"Immunity"},{"key":"733_CR127","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.3748\/wjg.v24.i45.5063","volume":"24","author":"A Lamas-Paz","year":"2018","unstructured":"Lamas-Paz, A. et al. Alcoholic liver disease: utility of animal models. World J. Gastroenterol. 24, 5063\u20135075 (2018).","journal-title":"World J. Gastroenterol."},{"key":"733_CR128","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/1756283X10378925","volume":"4","author":"TH Frazier","year":"2011","unstructured":"Frazier, T. H., Stocker, A. M., Kershner, N. A., Marsano, L. S. & McClain, C. J. Treatment of alcoholic liver disease. Ther. Adv. Gastroenterol. 4, 63\u201381 (2011).","journal-title":"Ther. Adv. Gastroenterol."},{"key":"733_CR129","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41422-019-0242-8","volume":"29","author":"S Wang","year":"2019","unstructured":"Wang, S. et al. Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury. Cell Res. 29, 1009\u20131026 (2019).","journal-title":"Cell Res."},{"key":"733_CR130","doi-asserted-by":"publisher","DOI":"10.1101\/2021.06.29.450347","author":"HY Tsang","year":"2021","unstructured":"Tsang, H. Y., Yi Lo, P. H. & Ho Lee, K. K. Generation of liver organoids from human induced pluripotent stem cells as liver fibrosis and steatosis models. bioRxiv https:\/\/doi.org\/10.1101\/2021.06.29.450347 (2021).","journal-title":"bioRxiv"},{"key":"733_CR131","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/hep.31857","volume":"74","author":"S McCarron","year":"2021","unstructured":"McCarron, S. et al. Functional characterization of organoids derived from irreversibly damaged liver of patients with NASH. Hepatology 74, 1825\u20131844 (2021).","journal-title":"Hepatology"},{"key":"733_CR132","doi-asserted-by":"publisher","first-page":"119823","DOI":"10.1016\/j.biomaterials.2020.119823","volume":"237","author":"M Elbadawy","year":"2020","unstructured":"Elbadawy, M. et al. Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model. Biomaterials 237, 119823 (2020).","journal-title":"Biomaterials"},{"key":"733_CR133","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease\u2013meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384 (2016).","journal-title":"Hepatology"},{"key":"733_CR134","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461\u20131465 (2008).","journal-title":"Nat. Genet."},{"key":"733_CR135","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3390\/ijms20071629","volume":"20","author":"P Pingitore","year":"2019","unstructured":"Pingitore, P. et al. Human multilineage 3D spheroids as a model of liver steatosis and fibrosis. Int. J. Mol. Sci. 20, 1629 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"733_CR136","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.3390\/cells9102247","volume":"9","author":"BE Schwartz","year":"2020","unstructured":"Schwartz, B. E. et al. Discovery and targeting of the signaling controls of PNPLA3 to effectively reduce transcription, expression, and function in pre-clinical NAFLD\/NASH settings. Cells 9, 2247 (2020).","journal-title":"Cells"},{"key":"733_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47737-w","volume":"9","author":"S Prill","year":"2019","unstructured":"Prill, S. et al. The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids. Sci. Rep. 9, 11585 (2019).","journal-title":"Sci. Rep."},{"key":"733_CR138","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/gutjnl-2020-320646","volume":"70","author":"Y Tanaka","year":"2021","unstructured":"Tanaka, Y. et al. LPIAT1\/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover. Gut 70, 180\u2013193 (2021).","journal-title":"Gut"},{"key":"733_CR139","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1126\/science.aah4965","volume":"354","author":"J Bass","year":"2016","unstructured":"Bass, J. & Lazar, M. A. Circadian time signatures of fitness and disease. Science 354, 994\u2013999 (2016).","journal-title":"Science"},{"key":"733_CR140","doi-asserted-by":"publisher","first-page":"eaao0318","DOI":"10.1126\/science.aao0318","volume":"359","author":"LS Mure","year":"2018","unstructured":"Mure, L. S. et al. Diurnal transcriptome atlas of a primate across major neural and peripheral tissues. Science 359, eaao0318 (2018).","journal-title":"Science"},{"key":"733_CR141","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021110157","volume":"41","author":"RG Yamada","year":"2022","unstructured":"Yamada, R. G. & Ueda, H. R. The circadian clock ticks in organoids. EMBO J. 41, e110157 (2022).","journal-title":"EMBO J."},{"key":"733_CR142","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106973","volume":"41","author":"AE Rosselot","year":"2022","unstructured":"Rosselot, A. E. et al. Ontogeny and function of the circadian clock in intestinal organoids. EMBO J. 41, e106973 (2022).","journal-title":"EMBO J."},{"key":"733_CR143","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.jhep.2019.06.030","volume":"71","author":"SJ Mun","year":"2019","unstructured":"Mun, S. J. et al. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids. J. Hepatol. 71, 970\u2013985 (2019).","journal-title":"J. Hepatol."},{"key":"733_CR144","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.nut.2017.01.009","volume":"38","author":"JBS Morais","year":"2017","unstructured":"Morais, J. B. S. et al. Effect of magnesium supplementation on insulin resistance in humans: a systematic review. Nutrition 38, 54\u201360 (2017).","journal-title":"Nutrition"},{"key":"733_CR145","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/tox.23021","volume":"36","author":"GR Romualdo","year":"2021","unstructured":"Romualdo, G. R. et al. Sorafenib reduces steatosis-induced fibrogenesis in a human 3D co-culture model of non-alcoholic fatty liver disease. Env. Toxicol. 36, 168\u2013176 (2021).","journal-title":"Env. Toxicol."},{"key":"733_CR146","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.addr.2014.02.006","volume":"69-70","author":"A Ranga","year":"2014","unstructured":"Ranga, A., Gjorevski, N. & Lutolf, M. P. Drug discovery through stem cell-based organoid models. Adv. Drug Deliv. Rev. 69-70, 19\u201328 (2014).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"733_CR147","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.chembiol.2016.08.010","volume":"23","author":"Y Chen","year":"2016","unstructured":"Chen, Y. et al. Histone demethylase LSD1 promotes adipocyte differentiation through repressing Wnt signaling. Cell Chem. Biol. 23, 1228\u20131240 (2016).","journal-title":"Cell Chem. Biol."},{"key":"733_CR148","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.celrep.2016.12.062","volume":"18","author":"B Nie","year":"2017","unstructured":"Nie, B. et al. Brown adipogenic reprogramming induced by a small molecule. Cell Rep. 18, 624\u2013635 (2017).","journal-title":"Cell Rep."},{"key":"733_CR149","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ebiom.2018.10.019","volume":"37","author":"Y Qiu","year":"2018","unstructured":"Qiu, Y. et al. Screening of FDA-approved drugs identifies sutent as a modulator of UCP1 expression in brown adipose tissue. EBioMedicine 37, 344\u2013355 (2018).","journal-title":"EBioMedicine"},{"key":"733_CR150","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.celrep.2018.10.036","volume":"25","author":"R Jing","year":"2018","unstructured":"Jing, R. et al. A screen using iPSC-derived hepatocytes reveals NAD(+) as a potential treatment for mtDNA depletion syndrome. Cell Rep. 25, 1469\u20131484.e5 (2018).","journal-title":"Cell Rep."},{"key":"733_CR151","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/jvim.15670","volume":"34","author":"MW Haaker","year":"2020","unstructured":"Haaker, M. W. et al. Identification of potential drugs for treatment of hepatic lipidosis in cats using an in vitro feline liver organoid system. J. Vet. Intern. Med. 34, 132\u2013138 (2020).","journal-title":"J. Vet. Intern. Med."},{"key":"733_CR152","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.2337\/dc15-2464","volume":"39","author":"AY Dawed","year":"2016","unstructured":"Dawed, A. Y. et al. CYP2C8 and SLCO1B1 variants and therapeutic response to thiazolidinediones in patients with type 2 diabetes. Diabetes Care 39, 1902\u20131908 (2016).","journal-title":"Diabetes Care"},{"key":"733_CR153","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3390\/ijms17101714","volume":"17","author":"VM Lauschke","year":"2016","unstructured":"Lauschke, V. M. & Ingelman-Sundberg, M. The importance of patient-specific factors for hepatic drug response and toxicity. Int. J. Mol. Sci. 17, 1714 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"733_CR154","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.cmet.2014.08.005","volume":"20","author":"RE Soccio","year":"2014","unstructured":"Soccio, R. E., Chen, E. R. & Lazar, M. A. Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell Metab. 20, 573\u2013591 (2014).","journal-title":"Cell Metab."},{"key":"733_CR155","doi-asserted-by":"publisher","first-page":"18745","DOI":"10.1073\/pnas.0903032106","volume":"106","author":"DD Sears","year":"2009","unstructured":"Sears, D. D. et al. Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization. Proc. Natl Acad. Sci. USA 106, 18745\u201318750 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"733_CR156","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.stem.2018.11.018","volume":"24","author":"W Hu","year":"2019","unstructured":"Hu, W. et al. Patient adipose stem cell-derived adipocytes reveal genetic variation that predicts antidiabetic drug response. Cell Stem Cell 24, 299\u2013308.e6 (2019).","journal-title":"Cell Stem Cell"},{"key":"733_CR157","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0022-2275(20)31566-2","volume":"42","author":"JF Oram","year":"2001","unstructured":"Oram, J. F. & Lawn, R. M. ABCA1. The gatekeeper for eliminating excess tissue cholesterol. J. Lipid Res. 42, 1173\u20131179 (2001).","journal-title":"J. Lipid Res."},{"key":"733_CR158","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.cmet.2021.06.004","volume":"33","author":"W Hu","year":"2021","unstructured":"Hu, W. et al. Individual-specific functional epigenomics reveals genetic determinants of adverse metabolic effects of glucocorticoids. Cell Metab. 33, 1592\u20131609.e7 (2021).","journal-title":"Cell Metab."},{"key":"733_CR159","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"RC Group","year":"2021","unstructured":"Group, R. C. et al. Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med. 384, 693\u2013704 (2021).","journal-title":"N. Engl. J. Med."},{"key":"733_CR160","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","volume":"18","author":"J Drost","year":"2018","unstructured":"Drost, J. & Clevers, H. Organoids in cancer research. Nat. Rev. Cancer 18, 407\u2013418 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"733_CR161","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M van de Wetering","year":"2015","unstructured":"van de Wetering, M. et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161, 933\u2013945 (2015).","journal-title":"Cell"},{"key":"733_CR162","doi-asserted-by":"publisher","first-page":"105608","DOI":"10.1016\/j.phrs.2021.105608","volume":"169","author":"A Brooks","year":"2021","unstructured":"Brooks, A. et al. Liver organoid as a 3D in vitro model for drug validation and toxicity assessment. Pharmacol. Res. 169, 105608 (2021).","journal-title":"Pharmacol. Res."},{"key":"733_CR163","doi-asserted-by":"publisher","first-page":"767621","DOI":"10.3389\/fgene.2021.767621","volume":"12","author":"T Matsui","year":"2021","unstructured":"Matsui, T. & Shinozawa, T. Human organoids for predictive toxicology research and drug development. Front. Genet. 12, 767621 (2021).","journal-title":"Front. Genet."},{"key":"733_CR164","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-med-051215-031129","volume":"68","author":"EM Kennedy","year":"2017","unstructured":"Kennedy, E. M. & Cullen, B. R. Gene editing: a new tool for viral disease. Annu. Rev. Med. 68, 401\u2013411 (2017).","journal-title":"Annu. Rev. Med."},{"key":"733_CR165","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.stem.2019.05.008","volume":"24","author":"J Roper","year":"2019","unstructured":"Roper, J. & Yilmaz, O. H. Breakthrough moments: genome editing and organoids. Cell Stem Cell 24, 841\u2013842 (2019).","journal-title":"Cell Stem Cell"},{"key":"733_CR166","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1007\/s00125-020-05367-2","volume":"64","author":"D Melton","year":"2021","unstructured":"Melton, D. The promise of stem cell-derived islet replacement therapy. Diabetologia 64, 1030\u20131036 (2021).","journal-title":"Diabetologia"},{"key":"733_CR167","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s41232-019-0106-0","volume":"39","author":"M Umekage","year":"2019","unstructured":"Umekage, M., Sato, Y. & Takasu, N. Overview: an iPS cell stock at CiRA. Inflamm. Regen. 39, 17 (2019).","journal-title":"Inflamm. Regen."},{"key":"733_CR168","doi-asserted-by":"publisher","first-page":"eaaz8664","DOI":"10.1126\/scitranslmed.aaz8664","volume":"12","author":"CH Wang","year":"2020","unstructured":"Wang, C. H. et al. CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice. Sci. Transl. Med. 12, eaaz8664 (2020).","journal-title":"Sci. Transl. Med."},{"key":"733_CR169","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27190-y","volume":"12","author":"E Tsagkaraki","year":"2021","unstructured":"Tsagkaraki, E. et al. CRISPR-enhanced human adipocyte browning as cell therapy for metabolic disease. Nat. Commun. 12, 6931 (2021).","journal-title":"Nat. Commun."},{"key":"733_CR170","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19136-7","volume":"11","author":"IF Schene","year":"2020","unstructured":"Schene, I. F. et al. Prime editing for functional repair in patient-derived disease models. Nat. Commun. 11, 5352 (2020).","journal-title":"Nat. Commun."},{"key":"733_CR171","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nrgastro.2013.88","volume":"10","author":"A Zarrinpar","year":"2013","unstructured":"Zarrinpar, A. & Busuttil, R. W. Liver transplantation: past, present and future. Nat. Rev. Gastroenterol. Hepatol. 10, 434\u2013440 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"733_CR172","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1038\/s41596-018-0036-3","volume":"13","author":"R Cruz-Acuna","year":"2018","unstructured":"Cruz-Acuna, R. et al. PEG-4MAL hydrogels for human organoid generation, culture, and in vivo delivery. Nat. Protoc. 13, 2102\u20132119 (2018).","journal-title":"Nat. Protoc."},{"key":"733_CR173","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201801621","volume":"30","author":"N Broguiere","year":"2018","unstructured":"Broguiere, N. et al. Growth of epithelial organoids in a defined hydrogel. Adv. Mater. 30, e1801621 (2018).","journal-title":"Adv. Mater."},{"key":"733_CR174","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.stem.2019.05.005","volume":"24","author":"JA Brassard","year":"2019","unstructured":"Brassard, J. A. & Lutolf, M. P. Engineering stem cell self-organization to build better organoids. Cell Stem Cell 24, 860\u2013876 (2019).","journal-title":"Cell Stem Cell"},{"key":"733_CR175","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41578-021-00279-y","volume":"6","author":"M Hofer","year":"2021","unstructured":"Hofer, M. & Lutolf, M. P. Engineering organoids. Nat. Rev. Mater. 6, 402\u2013420 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"733_CR176","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202104451","volume":"9","author":"J Rogal","year":"2022","unstructured":"Rogal, J. et al. Autologous human immunocompetent white adipose tissue-on-chip. Adv. Sci. 9, e2104451 (2022).","journal-title":"Adv. Sci."},{"key":"733_CR177","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.biomaterials.2015.08.043","volume":"71","author":"K Rennert","year":"2015","unstructured":"Rennert, K. et al. A microfluidically perfused three dimensional human liver model. Biomaterials 71, 119\u2013131 (2015).","journal-title":"Biomaterials"},{"key":"733_CR178","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.actbio.2017.12.042","volume":"69","author":"PL Lewis","year":"2018","unstructured":"Lewis, P. L., Green, R. M. & Shah, R. N. 3D-printed gelatin scaffolds of differing pore geometry modulate hepatocyte function and gene expression. Acta Biomater. 69, 63\u201370 (2018).","journal-title":"Acta Biomater."},{"key":"733_CR179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13619-021-00103-6","volume":"11","author":"X Lu","year":"2022","unstructured":"Lu, X., Yang, J. & Xiang, Y. Modeling human neurodevelopmental diseases with brain organoids. Cell Regen. 11, 1 (2022).","journal-title":"Cell Regen."},{"key":"733_CR180","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.cell.2020.11.017","volume":"183","author":"J Andersen","year":"2020","unstructured":"Andersen, J. et al. Generation of functional human 3D cortico-motor assembloids. Cell 183, 1913\u20131929.e26 (2020).","journal-title":"Cell"},{"key":"733_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14815-w","volume":"7","author":"S Bauer","year":"2017","unstructured":"Bauer, S. et al. Functional coupling of human pancreatic islets and liver spheroids on-a-chip: towards a novel human ex vivo type 2 diabetes model. Sci. Rep. 7, 14620 (2017).","journal-title":"Sci. Rep."},{"key":"733_CR182","doi-asserted-by":"publisher","first-page":"1801954","DOI":"10.1002\/adfm.201801954","volume":"28","author":"Y Jin","year":"2018","unstructured":"Jin, Y. et al. Vascularized liver organoids generated using induced hepatic tissue and dynamic liver-specific microenvironment as a drug testing platform. Adv. Funct. Mater. 28, 1801954 (2018).","journal-title":"Adv. Funct. Mater."},{"key":"733_CR183","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1021\/bp034238d","volume":"20","author":"K Viravaidya","year":"2004","unstructured":"Viravaidya, K. & Shuler, M. L. Incorporation of 3T3-L1 cells to mimic bioaccumulation in a microscale cell culture analog device for toxicity studies. Biotechnol. Prog. 20, 590\u2013597 (2004).","journal-title":"Biotechnol. Prog."},{"key":"733_CR184","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1002\/bit.25989","volume":"113","author":"PG Miller","year":"2016","unstructured":"Miller, P. G. & Shuler, M. L. Design and demonstration of a pumpless 14 compartment microphysiological system. Biotechnol. Bioeng. 113, 2213\u20132227 (2016).","journal-title":"Biotechnol. Bioeng."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-022-00733-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-022-00733-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-022-00733-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:15:18Z","timestamp":1733940918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-022-00733-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":184,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["733"],"URL":"https:\/\/doi.org\/10.1038\/s41574-022-00733-z","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"assertion":[{"value":"27 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.A.L. is an advisory board member for Pfizer Inc., a consultant to Madrigal and Calico, and receives support from Pfizer for research not overlapping with the work reported here. W.H. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}